Adam is Head of Pricing and Contracting for UK and Ireland at Boehringer Ingelheim, working across the whole Boehringer Ingelheim prescription medicines portfolio. Before moving to the UK in 2015, Adam was a Senior Global Payer Strategy Manager working in oncology pipeline at Boehringer Ingelheim in Ingelheim, Germany. He was managing global pricing and market access strategies for the oncology portfolio and driving the development of innovative market access approaches and payment schemes.
Prior to joining Boehringer Ingelheim Adam worked as a life sciences strategy consultant for IMS Consulting, IBM Watson Health and Simon-Kucher & Partners in Belgium, France, Germany, Poland, Romania and The United States. He also worked as a research assistant at Jules Gonin Eye Hospital in Lausanne, Switzerland and as a Junior Project Leader at AnalyCen in Poland and Sweden.
Adam holds a M.Sc. in Molecular Biology and Biotechnology from University of Warsaw, Poland, and a Ph.D. in Neurosciences from University of Geneva, University of Lausanne and EPFL, Switzerland. He has published several articles in international peer reviewed journals, and lectured at international conferences on developmental neuroscience and retinal degeneration.